Imnet shares plummet on news of SEC inquiryThe stock of information systems developer Imnet Systems plunged 34% late last month after the Atlanta company announced that the release of its year-end financial statements would be delayed because
The stock of information systems developer Imnet Systems plunged 34% late last month after the Atlanta company announced that the release of its year-end financial statements would be delayed because its auditor needed additional time to complete the company's audit.
Imnet executives said its auditor, KPMG Peat Marwick, might need the extra time to respond to a confidential informal inquiry made by the Securities and Exchange Commission, which has received anonymous letters regarding the company's financial statements. Imnet shares fell $13.63 to close at $26.88 on Sept. 30, the day the news was announced.
Imnet chairman and CEO Kenneth Rardin stressed that the auditors have not proposed any adjustments to Imnet's financial statements, nor have the auditors had any disagreements with the company over the statements. Rardin said that his company had reviewed the allegations in the letters and determined them to be without merit, and that the company's previously announced financial statements are accurate.
Imnet declined to comment on the nature of the allegations in the letters sent to the SEC. There has been some concern among industry analysts, however, over the size of the company's backlog, which grew to $51 million at the end of the fourth quarter, up 111% compared with $24.2 million at the end of 1996 (PNN 9/97).
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.
2 Commerce Drive
Cranbury, NJ 08512